Booster Shots in Children Ages 5–11 , Increase Omicron Antibodies, Pfizer Says.<br />NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14.<br />NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14.<br />Given half a year after the initial series of two doses, a booster shot of the Pfizer-BioNTech vaccine increased antibody levels sixfold.<br />In Pfizer's clinical trial, 140 children ages <br />5 through 11 received a booster shot.<br />According to NBC News, data has <br />not yet been made available to <br />independent researchers for review.<br />In the era of Omicron, booster doses of <br />COVID vaccines have been hit and miss.<br />In adults, a booster dose of Pfizer's vaccine wanes dramatically after four months.<br />Health experts say the same trends <br />are likely to occur in children.<br />For adults, Pfizer's vaccine <br />is 30 micrograms per dose.<br />For children, vaccines are <br />10 micrograms per dose.<br />Earlier this year, New York Department <br />of Health researchers found Pfizer's <br />vaccine to offer minimal protection <br />against infection in children.<br />But according to NBC, the CDC later said <br />two doses in children offered ample protection against severe infections.<br />But according to NBC, the CDC later said <br />two doses in children offered ample protection against severe infections
